NCT03337126View on ClinicalTrials.gov

Bioavailability of ATI-1501 With Taste Test Sub Study

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

December 13, 2017

Study Completion Date

December 30, 2017

Conditions
Bioequivalence
Interventions
DRUG

Metronidazole Tablet

Comparator Drug

Trial Locations (1)

M5V2T3

INC Research Inc., Toronto

Sponsors

Collaborators (1)

Syneos Health
All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Appili Therapeutics Inc.

INDUSTRY